Characterization of a ricin fusion toxin targeted to the interleukin-2 receptor

被引:11
|
作者
Frankel, AE
Burbage, C
Fu, T
Tagge, E
Chandler, J
Willingham, M
机构
[1] MED UNIV S CAROLINA,DEPT SURG,CHARLESTON,SC 29425
[2] MED UNIV S CAROLINA,DEPT PATHOL,CHARLESTON,SC 29425
来源
PROTEIN ENGINEERING | 1996年 / 9卷 / 10期
关键词
IL-2 fusion toxin; ricin;
D O I
10.1093/protein/9.10.913
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fusion toxins are hybrid proteins consisting of peptide ligands linked through amide bonds to polypeptide toxins. The ligand directs the molecule to the surface of target cells and the toxin enters the cytosol and induces cell death, Ricin is an excellent candidate for use in fusion toxins because of its extreme potency, the extensive knowledge of its atomic structure and the lack of prior immunological exposure in patients. We synthesized a baculovirus transfer vector with the polyhedrin promoter followed sequentially from the 5' end with DNA encoding the gp67A leader sequence, the tripeptide ADP, IL-2 (interleukin-2), another ADP tripeptide and RTB (ricin toxin B chain) with lectin-site mutations W37S and Y248H, Recombinant baculovirus was generated in Sf9 insect cells and used to infect Sf9 cells, Recombinant IL-2-RTB[W37S/Y248H] protein (fusion protein of IL-2 with modifications W37S and Y238H) was recovered at high yields from day 6 insect cell supernatants, partially purified by affinity chromatography and reassociated with RTA (ricin toxin A chain), The fusion toxin was soluble. immunoreactive with antibodies to RTB, IL-2 and RTA and had a molecular weight of 80 kDa by SDS-PAGE. The molecule reacted poorly with asialofetuin, but bound strongly to IL-2 receptor based on selective cytotoxicity to IL-2 receptor bearing cells, The specific cytotoxicity could be blocked with IL-2 but not lactose, Thus, we report a novel targeted fusion toxin protein with full biological activity.
引用
收藏
页码:913 / 919
页数:7
相关论文
共 50 条
  • [1] INTERLEUKIN-2 RECEPTOR TARGETED CYTO-TOXICITY INTERLEUKIN-2 RECEPTOR MEDIATED ACTION OF A DIPHTHERIA-TOXIN RELATED INTERLEUKIN-2 FUSION PROTEIN
    BACHA, P
    WILLIAMS, DP
    WATERS, C
    WILLIAMS, JM
    MURPHY, JR
    STROM, TB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (02): : 612 - 622
  • [2] INTERLEUKIN-2 RECEPTOR-TARGETED CYTOTOXICITY - RECEPTOR-BINDING REQUIREMENTS FOR ENTRY OF A DIPHTHERIA TOXIN-RELATED INTERLEUKIN-2 FUSION PROTEIN INTO CELLS
    WATERS, CA
    SCHIMKE, PA
    SNIDER, CE
    ITOH, K
    SMITH, KA
    NICHOLS, JC
    STROM, TB
    MURPHY, JR
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (04) : 785 - 791
  • [3] Interleukin-2 fusion toxin: Targeted therapy for cutaneous T cell lymphoma
    Foss, FM
    [J]. CUTANEOUS T CELL LYMPHOMA: BASIC AND CLINICALLY RELEVANT BIOLOGY, 2001, 941 : 166 - 176
  • [4] CELL-RECEPTOR SPECIFIC TARGETED TOXINS - GENETIC CONSTRUCTION AND CHARACTERIZATION OF AN INTERLEUKIN-2 DIPHTHERIA TOXIN-RELATED FUSION PROTEIN
    MURPHY, JR
    WILLIAMS, DP
    BACHA, P
    BISHAI, W
    WATERS, C
    STROM, TB
    [J]. JOURNAL OF RECEPTOR RESEARCH, 1988, 8 (1-4): : 467 - 480
  • [5] Suppression of murine experimental autoimmune encephalomyelitis by interleukin-2 receptor targeted fusion toxin, DAB389IL-2
    Phillips, S. Michael
    Bhopale, Mahendra K.
    Hilliard, Brendan
    Zekavat, Seyed Ali
    Ali, Mohamad Anwar Ramadan
    Rostami, Abdolmohamad
    [J]. CELLULAR IMMUNOLOGY, 2010, 261 (02) : 144 - 152
  • [6] INTERLEUKIN-2 RECEPTOR TARGETED FUSION TOXINS BLOCK DIABETES IN NOD MICE
    NAITO, T
    PRICE, D
    BACHA, P
    NICHOLS, J
    STROM, T
    KELLEY, VR
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 970 - 970
  • [7] INTERLEUKIN-2 RECEPTOR TARGETED TOXICITY - IL-2 RECEPTOR REQUIREMENTS FOR THE ACTION OF IL-2-TOXIN
    MURPHY, JR
    WATERS, C
    SCHIMKE, P
    STROM, TB
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1989, 198 : 138 - MBTD
  • [8] DIPHTHERIA-TOXIN RECEPTOR-BINDING DOMAIN SUBSTITUTION WITH INTERLEUKIN-2 - GENETIC CONSTRUCTION AND PROPERTIES OF A DIPHTHERIA TOXIN-RELATED INTERLEUKIN-2 FUSION PROTEIN
    WILLIAMS, DP
    PARKER, K
    BACHA, P
    BISHAI, W
    BOROWSKI, M
    GENBAUFFE, F
    STROM, TB
    MURPHY, JR
    [J]. PROTEIN ENGINEERING, 1987, 1 (06): : 493 - 498
  • [9] SOLUBLE INTERLEUKIN-2 RECEPTOR - A NEW UREMIC TOXIN
    CARDELLA, CJ
    WEISSGARTEN, J
    SHOKER, A
    DELUCA, L
    NG, CM
    FRIEDMAN, E
    [J]. KIDNEY INTERNATIONAL, 1990, 37 (01) : 500 - 500
  • [10] Interleukin-2 fusion protein: An investigational therapy for interleukin-2 receptor expressing malignancies
    Nichols, J
    Foss, F
    Kuzel, TM
    LeMaistre, CF
    Platanias, L
    Ratain, MJ
    Rook, A
    Saleh, M
    Schwartz, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : S34 - S36